- Presentations
- 0
- Brands
- 0
- Manufacturers
- 0
- Available from stock
- 0
Herpes zoster vaccine (recombinant, adjuvanted) is a medicine. It is available for export supply from India to licensed hospitals, importers and physicians, with the documents the destination country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- ATC classification
- J07BK03 Herpes zoster vaccine (recombinant, adjuvanted) · Viral vaccines, subgroup J07BK
- US FDA first approval
- Not recorded
- EU status
- Authorised
- Orphan designation
- No
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Biologic
- Yes
All presentations
No presentations of Herpes zoster vaccine (recombinant, adjuvanted) are listed yet. Ask us to source it
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
Questions and answers
Is Herpes zoster vaccine (recombinant, adjuvanted) available for export from India?
No presentation of Herpes zoster vaccine (recombinant, adjuvanted) is listed yet, but our sourcing team can check licensed channels. Send a request with the strength, quantity and destination country.
Is Herpes zoster vaccine (recombinant, adjuvanted) authorised in the European Union?
Yes. Herpes zoster vaccine (recombinant, adjuvanted) has a central EU marketing authorisation (status: authorised), according to European Medicines Agency data.
Does Herpes zoster vaccine (recombinant, adjuvanted) need cold chain shipping?
No listed presentation of Herpes zoster vaccine (recombinant, adjuvanted) is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Which ATC class is Herpes zoster vaccine (recombinant, adjuvanted) in?
Herpes zoster vaccine (recombinant, adjuvanted) is classified under ATC code J07BK03 (Herpes zoster vaccine (recombinant, adjuvanted)).
References
- Shingrix: European public assessment report (EPAR). European Medicines Agency. Retrieved 20 October 2026
Request Herpes zoster vaccine (recombinant, adjuvanted) for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.